Research and Development

Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …

Pharma’s M&A train keeps on going as news breaks that Allergan has picked up University of Sydney spin-off Elastagen for …

England is not alone in being particularly hard hit this flu season, with Australia suffering its worst flu season in …

Allergan had a rough year in 2017, dropping by close to $80 a share from February 2017 to this month. …

Allergan has been searching for a new Chief Financial Officer since Tessa Hilado, its current CFO, revealed that she would …

The UK Government has confirmed a national vaccination programme that will provide access for men who have sex with men(MSM) …

Bristol-Myers Squibb has revealed promising data from its ongoing Phase 3 study investigating the efficacy of Opdivo (nivolumab) in combination …

Abbott is set to join forces with liquid biopsy medtech firm Angle to collaborate on a study into metastatic breast …

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …

Breast cancer deaths in the UK have fallen by 10% in the past five years, according to research released by …

It’s the first Friday of February, and it’s time for another recap of the top ten articles most popular with …

Bad news for breast cancer patients in the UK as the National Institute for Health and Care Excellence announces it …

Pharmafile.com met with Marco Avila, Vice President of Medical Affairs at Teva Europe to discuss his life in the industry, …

Texas-based clinical-stage company Bellicum Pharmaceuticals has taken a massive stock hit after the FDA put a hold on its trials …

To say January was a bleak month for Alzheimer’s research would be something of an understatement: Pfizer ducked out of …